Scholarly Works

Does spironolactone reduce the risk of urinary...

Journal article

Does spironolactone reduce the risk of urinary tract cancers in hypertensive patients?

Authors

Teo KK

Journal

Journal of Hypertension, Vol. 35, No. 1, pp. 36–38

Publisher

Wolters Kluwer

Publication Date

January 1, 2017

DOI

10.1097/hjh.0000000000001157

ISSN

0263-6352

Associated Experts

Koon Teo

Professor Emeritus, FHSMED

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3201 Cardiovascular medicine and haematology 3202 Clinical sciences

Medical Subject Headings (MeSH)

Angiotensin-Converting Enzyme Inhibitors Case-Control Studies Humans Hypertension Mineralocorticoid Receptor Antagonists Odds Ratio Retrospective Studies Risk Spironolactone Urologic Neoplasms

View published work (Non-McMaster Users)

View published work (McMaster Users)

Contact the Experts team

Get technical help

or

Provide website feedback